Erfolgsrechnungen von Haemonetics HAE

Gewinn- und Verlustrechnung

Quarter End	Apr 2022	Jul 2022	Okt 2022	Dez 2022	Apr 2023	Jul 2023	Sep 2023	Dez 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Gesamteinnahmen	265M	261,46M	297,87M	305,3M	304,42M	311,33M	318,18M	336,25M
Betriebseinkommen	19,78M	30,77M	46,73M	43,28M	35,26M	53,66M	35,3M	45,98M
Einkommen vor Steuern	15,33M	25,49M	41,06M	42,22M	32,63M	51,59M	32,83M	44,03M
Nettoeinkommen	9,74M	19,88M	33,2M	32,94M	29,38M	41,04M	24,91M	31,24M
Bevorzugte Dividenden	0	0	0	0	0	0	0	0
Grundlegendes Gewinn pro Aktie (EPS)	0	0	0	0	0	0	0	0
EBIT	19,78M	30,77M	42,15M	43,28M	35,64M	53,66M	35,3M	45,98M
EBITDA	56,07M	61,58M	78,39M	74,93M	34,44M	76,69M	68,74M	69,51M

Jahresende 01 April 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Gesamteinnahmen	913,56M	886,12M	903,92M	967,58M	988,48M	903,28M	1B	1,17B
Betriebseinkommen	-43,94M	-19,38M	56,16M	83,55M	153,95M	90,78M	81,33M	155,65M
Einkommen vor Steuern	-53,42M	-27,48M	59,63M	73,63M	87,15M	72,91M	63,63M	141,4M
Nettoeinkommen	-55,58M	-26,27M	45,57M	55,02M	76,53M	79,47M	43,38M	115,4M
Bevorzugte Dividenden	0	0	0	0	0	0	0	0
Grundlegendes Gewinn pro Aktie (EPS)	-1.091	-0.503	0.871	1.078	1.521	1.562	0.848	2.288
EBIT	-53,52M	-28,33M	64,16M	73,63M	133,9M	73,94M	81,33M	156,03M
EBITDA	147,21M	145,45M	147,9M	194,36M	264,74M	175,06M	226,49M	248,96M